Watch AVAI. Know when insiders buy.
One email the day a filing lands. Free.
AVAI
AVAI BIO, INC.
0.12
+0.01 +4.27%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $18.8MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$1.8MNET CASH $54K52W 0.11 – 0.78SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | — | — | — | −$552K | −$552K | −213.2% | 0.00 | −$414K | — | — | Aug 13 |
| Q4 2026 · Mar 31derived | — | — | — | −$255K | −$255K | −155.0% | 0.00 | −$51K | — | — | Jul 14 |
| Q3 2026 · Dec 31 | — | — | — | −$554K | −$554K | — | 0.00 | −$347K | — | — | Feb 12 |
| Q2 2026 · Sep 30 | — | — | — | −$453K | −$453K | — | 0.00 | −$372K | — | — | Feb 12 |
| Q1 2026 · Jun 30 | — | — | — | $488K | $488K | — | 0.00 | −$240K | — | — | Aug 13 |
| Q4 2025 · Mar 31derived | — | — | — | −$2.7M | $464K | — | 0.00 | −$188K | — | — | Jul 14 |
| Q3 2025 · Dec 31 | — | — | — | $452K | −$452K | — | 0.00 | −$134K | — | — | Feb 12 |
| Q2 2025 · Sep 30 | — | — | — | $623K | −$625K | — | -0.01 | −$826K | — | — | Feb 12 |
| Q1 2025 · Jun 30 | — | — | — | −$529K | −$529K | — | 0.00 | −$13K | — | — | Feb 12 |
| Q4 2024 · Mar 31derived | — | — | — | −$4M | −$4M | — | 0.01 | −$137K | — | — | Jul 8 |
| Q3 2024 · Dec 31 | — | — | — | $1M | −$1M | — | -0.01 | −$706K | — | — | Feb 7 |
| Q2 2024 · Sep 30 | — | — | — | $400K | −$400K | — | -0.01 | −$420K | — | — | Feb 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | — | — | −$1.7M | −$1.7M | — | -0.01 | −$1M | — | — | — | — |
| FY2025 · to Mar 31 | — | — | −$1.1M | −$1.1M | — | -0.01 | −$1.2M | — | — | — | — |
| FY2024 · to Mar 31 | — | — | −$2.1M | −$2.1M | — | -0.02 | −$1.3M | — | — | — | — |
| FY2023 · to Mar 31 | $276K | -14.6% | −$349K | −$349K | -126.3% | 0.00 | −$54K | — | — | — | — |
| FY2022 · to Mar 31 | — | — | $127K | −$127K | — | 0.00 | $535K | — | — | — | — |
| FY2021 · to Mar 31 | — | — | $302K | −$302K | — | 0.00 | $23K | — | — | — | — |
Every number comes from AVAI BIO, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.